138 related articles for article (PubMed ID: 1739922)
21. Assessment of Valvular Disorders in Survivors of Hodgkin's Lymphoma Treated by Mediastinal Radiotherapy ± Chemotherapy.
Bijl JM; Roos MM; van Leeuwen-Segarceanu EM; Vos JM; Bos WW; Biesma DH; Post MC
Am J Cardiol; 2016 Feb; 117(4):691-696. PubMed ID: 26772441
[TBL] [Abstract][Full Text] [Related]
22. Radiation-related coronary artery disease in Hodgkin's disease.
Leong AS; Forbes IJ; Ruzic T
Aust N Z J Med; 1979 Aug; 9(4):423-5. PubMed ID: 292383
[TBL] [Abstract][Full Text] [Related]
23. Long-term survival and competing causes of death in patients with early-stage Hodgkin's disease treated at age 50 or younger.
Ng AK; Bernardo MP; Weller E; Backstrand KH; Silver B; Marcus KC; Tarbell NJ; Friedberg J; Canellos GP; Mauch PM
J Clin Oncol; 2002 Apr; 20(8):2101-8. PubMed ID: 11956271
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of coronary artery disease by computed tomography angiography in patients treated for childhood Hodgkin's lymphoma.
Küpeli S; Hazirolan T; Varan A; Akata D; Alehan D; Hayran M; Besim A; Büyükpamukçu M
J Clin Oncol; 2010 Feb; 28(6):1025-30. PubMed ID: 20038721
[TBL] [Abstract][Full Text] [Related]
25. High-dose BEAM chemotherapy with autologous haemopoietic stem cell transplantation for Hodgkin's disease is unlikely to be associated with a major increased risk of secondary MDS/AML.
Harrison CN; Gregory W; Hudson GV; Devereux S; Goldstone AH; Hancock B; Winfield D; MacMillan AK; Hoskin P; Newland AC; Milligan D; Linch DC
Br J Cancer; 1999 Oct; 81(3):476-83. PubMed ID: 10507773
[TBL] [Abstract][Full Text] [Related]
26. Radiation-induced stenosis of the left main coronary artery.
Tenet W; Missri J; Hager D
Cathet Cardiovasc Diagn; 1986; 12(3):169-71. PubMed ID: 3731265
[TBL] [Abstract][Full Text] [Related]
27. [Ostial stenosis of the left main coronary artery after mediastinal radiotherapy. Apropos of a case].
Pillière R; Luquel L; Brun D; Jault F; Gandjbakhch I; Bourdarias JP
Arch Mal Coeur Vaiss; 1991 Jun; 84(6):869-72. PubMed ID: 1898223
[TBL] [Abstract][Full Text] [Related]
28. [Myocardial infarct, acute coronary insufficiency and sudden death in lymphogranulomatosis patients after irradiation of the mediastinum].
Baĭsogolov GD; Shishkin IP
Radiobiol Radiother (Berl); 1983; 24(2):165-70. PubMed ID: 6688135
[No Abstract] [Full Text] [Related]
29. Risk of second primary cancers after Hodgkin's disease by type of treatment: analysis of 2846 patients in the British National Lymphoma Investigation.
Swerdlow AJ; Douglas AJ; Hudson GV; Hudson BV; Bennett MH; MacLennan KA
BMJ; 1992 May; 304(6835):1137-43. PubMed ID: 1392790
[TBL] [Abstract][Full Text] [Related]
30. Second cancers following pediatric Hodgkin's disease.
Wolden SL; Lamborn KR; Cleary SF; Tate DJ; Donaldson SS
J Clin Oncol; 1998 Feb; 16(2):536-44. PubMed ID: 9469338
[TBL] [Abstract][Full Text] [Related]
31. Cumulative burden of cardiovascular morbidity in paediatric, adolescent, and young adult survivors of Hodgkin's lymphoma: an analysis from the St Jude Lifetime Cohort Study.
Bhakta N; Liu Q; Yeo F; Baassiri M; Ehrhardt MJ; Srivastava DK; Metzger ML; Krasin MJ; Ness KK; Hudson MM; Yasui Y; Robison LL
Lancet Oncol; 2016 Sep; 17(9):1325-34. PubMed ID: 27470081
[TBL] [Abstract][Full Text] [Related]
32. Second solid malignancies after combined modality therapy for Hodgkin's disease.
Doria R; Holford T; Farber LR; Prosnitz LR; Cooper DL
J Clin Oncol; 1995 Aug; 13(8):2016-22. PubMed ID: 7636543
[TBL] [Abstract][Full Text] [Related]
33. Increased mortality after successful treatment for Hodgkin's disease.
Hudson MM; Poquette CA; Lee J; Greenwald CA; Shah A; Luo X; Thompson EI; Wilimas JA; Kun LE; Crist WM
J Clin Oncol; 1998 Nov; 16(11):3592-600. PubMed ID: 9817280
[TBL] [Abstract][Full Text] [Related]
34. [Treatment and prognosis of intrathoracic Hodgkin's disease (author's transl)].
Jungblut R; Menne HJ
Dtsch Med Wochenschr; 1975 May; 100(22):1219-24. PubMed ID: 1132336
[TBL] [Abstract][Full Text] [Related]
35. Lung cancer after treatment for Hodgkin's lymphoma: a systematic review.
Lorigan P; Radford J; Howell A; Thatcher N
Lancet Oncol; 2005 Oct; 6(10):773-9. PubMed ID: 16198983
[TBL] [Abstract][Full Text] [Related]
36. Thyroid diseases after treatment of Hodgkin's disease.
Hancock SL; Cox RS; McDougall IR
N Engl J Med; 1991 Aug; 325(9):599-605. PubMed ID: 1861693
[TBL] [Abstract][Full Text] [Related]
37. Subsequent malignancies in children and adolescents after treatment for Hodgkin's disease.
Beaty O; Hudson MM; Greenwald C; Luo X; Fang L; Wilimas JA; Thompson EI; Kun LE; Pratt CB
J Clin Oncol; 1995 Mar; 13(3):603-9. PubMed ID: 7884422
[TBL] [Abstract][Full Text] [Related]
38. Risk of second cancers after treatment for Hodgkin's disease.
Tucker MA; Coleman CN; Cox RS; Varghese A; Rosenberg SA
N Engl J Med; 1988 Jan; 318(2):76-81. PubMed ID: 3336397
[TBL] [Abstract][Full Text] [Related]
39. Cardiovascular disease after Hodgkin lymphoma treatment: 40-year disease risk.
van Nimwegen FA; Schaapveld M; Janus CP; Krol AD; Petersen EJ; Raemaekers JM; Kok WE; Aleman BM; van Leeuwen FE
JAMA Intern Med; 2015 Jun; 175(6):1007-17. PubMed ID: 25915855
[TBL] [Abstract][Full Text] [Related]
40. Left ventricular function assessed by two-dimensional speckle tracking echocardiography in long-term survivors of Hodgkin's lymphoma treated by mediastinal radiotherapy with or without anthracycline therapy.
Tsai HR; Gjesdal O; Wethal T; Haugaa KH; Fosså A; Fosså SD; Edvardsen T
Am J Cardiol; 2011 Feb; 107(3):472-7. PubMed ID: 21257017
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
